RenustatTM

Roxadustat
HIF-PH inhibitor (Antianemic Drug)

Indication:
Roxadustat is indicated for the treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD).

Dosage & Administration:
Three times per week and not on consecutive days.

Preparation:
RenustatTM 50 Tablet: Each box contains 3 tablets in Alu-PVDC blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides